MML Investors Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,890
Closed -$231K 3019
2025
Q4
$231K Sell
3,890
-694
-15% -$37.8K ﹤0.01% 2798
2025
Q3
$248K Sell
4,584
-334
-7% -$19.1K ﹤0.01% 2644
2025
Q2
$270K Sell
4,918
-329
-6% -$19.4K ﹤0.01% 2491
2025
Q1
$371K Sell
5,247
-2,292
-30% -$154K ﹤0.01% 2189
2024
Q4
$496K Sell
7,539
-82
-1% -$5.49K ﹤0.01% 1921
2024
Q3
$536K Buy
7,621
+572
+8% +$47.8K ﹤0.01% 1817
2024
Q2
$580K Sell
7,049
-1,273
-15% -$106K ﹤0.01% 1696
2024
Q1
$727K Sell
8,322
-4,401
-35% -$394K ﹤0.01% 1593
2023
Q4
$1.23M Buy
12,723
+3,719
+41% +$329K 0.01% 1230
2023
Q3
$797K Buy
9,004
+550
+7% +$48.9K ﹤0.01% 1353
2023
Q2
$733K Buy
8,454
+2,024
+31% +$190K ﹤0.01% 1397
2023
Q1
$625K Buy
6,430
+426
+7% +$44.2K ﹤0.01% 1299
2022
Q4
$621K Buy
6,004
+78
+1% +$7.32K ﹤0.01% 1393
2022
Q3
$502K Buy
5,926
+165
+3% +$14.7K ﹤0.01% 1419
2022
Q2
$477K Sell
5,761
-2,995
-34% -$238K ﹤0.01% 1434
2022
Q1
$675K Sell
8,756
-5,214
-37% -$436K ﹤0.01% 1300
2021
Q4
$1.23M Buy
13,970
+772
+6% +$63.7K 0.01% 973
2021
Q3
$1.02M Sell
13,198
-222
-2% -$17.5K 0.01% 1006
2021
Q2
$1.12M Buy
13,420
+2,452
+22% +$194K 0.01% 952
2021
Q1
$828K Buy
10,968
+718
+7% +$58.7K 0.01% 1008
2020
Q4
$899K Sell
10,250
-257
-2% -$20.4K 0.01% 885
2020
Q3
$799K Sell
10,507
-1,202
-10% -$122K 0.01% 856
2020
Q2
$1.44M Sell
11,709
-809
-6% -$80.4K 0.02% 608
2020
Q1
$1.06M Buy
12,518
+290
+2% +$25K 0.02% 604
2019
Q4
$1.03M Buy
12,228
+251
+2% +$19K 0.01% 707
2019
Q3
$807K Sell
11,977
-1,560
-12% -$120K 0.01% 757
2019
Q2
$1.16M Buy
13,537
+1,810
+15% +$155K 0.02% 663
2019
Q1
$1.04M Buy
11,727
+2,545
+28% +$236K 0.02% 686
2018
Q4
$782K Buy
9,182
+1,469
+19% +$140K 0.01% 711
2018
Q3
$748K Buy
7,713
+3,009
+64% +$300K 0.01% 799
2018
Q2
$443K Buy
4,704
+1,905
+68% +$167K 0.01% 896
2018
Q1
$227K Buy
+2,799
New +$240K ﹤0.01% 1210

Other funds holding BMRN